{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T17:07:53Z","timestamp":1789319273481,"version":"build-2803163510"},"reference-count":38,"publisher":"AOSIS","issue":"1","license":[{"start":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T00:00:00Z","timestamp":1569801600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["South. Afr. j. HIV med."],"abstract":"<jats:p>Background: In 2013, a pregnancy exposure registry and birth defects surveillance (PER\/BDS) system was initiated in eThekwini District, KwaZulu-Natal (KZN), to assess the impact of antiretroviral treatment (ART) on birth outcomes.Objectives: At the end of the first year, we assessed the risk of major congenital malformations (CM) and other adverse birth outcomes (ABOs) detected at birth, in children born to women exposed to ART during pregnancy.Method: Data were collected from women who delivered at Prince Mshiyeni Memorial Hospital, Durban, from 07 October 2013 to 06 October 2014, using medicine exposure histories and birth outcomes from maternal interviews, clinical records and neonatal surface examination. Singleton births exposed to only one ART regimen were included in bivariable analysis for CM risk and multivariate risk analysis for ABO risk.Results: Data were collected from 10 417 women with 10 517 birth outcomes (4013 [38.5%] HIV-infected). Congenital malformations rates in births exposed to Efavirenz during the first trimester (T1) (RR 0.87 [95% CI 0.12\u20136.4; p = 0.895]) were similar to births not exposed to ART during T1. However, T1 exposure to Nevirapine was associated with the increased risk of CM (RR 9.28 [95% CI 2.3\u201337.9; p = 0.002]) when compared to the same group. Other ABOs were more frequent in the combination of HIV\/ART-exposed births compared to HIV-unexposed births (29.9% vs. 26.0%, adjusted RR 1.23 [1.14\u20131.31; p  0.001]).Conclusion: No association between T1 use of EFV-based ART regimens and CM was observed. Associations between T1 NVP-based ART regimen and CM need further investigation. HIV- and ART-exposed infants had more ABOs compared to HIV-unexposed infants.<\/jats:p>","DOI":"10.4102\/sajhivmed.v20i1.971","type":"journal-article","created":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T22:47:08Z","timestamp":1569538028000},"source":"Crossref","is-referenced-by-count":25,"title":["Birth outcomes following antiretroviral exposure during pregnancy: Initial results from a pregnancy exposure registry in South Africa"],"prefix":"10.4102","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0032-3171","authenticated-orcid":false,"given":"Ushma C.","family":"Mehta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5154-1390","authenticated-orcid":false,"given":"Cari","family":"Van Schalkwyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6025-5393","authenticated-orcid":false,"given":"Prineetha","family":"Naidoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4061-6320","authenticated-orcid":false,"given":"Arthi","family":"Ramkissoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4263-8040","authenticated-orcid":false,"given":"Otty","family":"Mhlongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9210-9913","authenticated-orcid":false,"given":"Niren R.","family":"Maharaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3912-8258","authenticated-orcid":false,"given":"Niree","family":"Naidoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2910-6306","authenticated-orcid":false,"given":"Karen","family":"Fieggen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9150-3620","authenticated-orcid":false,"given":"Michael F.","family":"Urban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0985-9474","authenticated-orcid":false,"given":"Shaun","family":"Krog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7139-7509","authenticated-orcid":false,"given":"Alex","family":"Welte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9355-5405","authenticated-orcid":false,"given":"Mukesh","family":"Dheda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3366-0892","authenticated-orcid":false,"given":"Yogan","family":"Pillay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6498-8762","authenticated-orcid":false,"given":"Neil F.","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2580","published-online":{"date-parts":[[2019,9,30]]},"reference":[{"key":"ref0001","first-page":"S4","volume":"3","author":"Moodley","year":"2018","journal-title":"SAMJ"},{"key":"ref0002","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2013.09.015"},{"key":"ref0003","author":"WHO","year":"2013","journal-title":"Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: Recommendations for a public health approach [homepage on the Internet]"},{"key":"ref0004","author":"National Department of Health, South Africa","year":"2013","journal-title":"National Consolidated guidelines for the prevention of mother-to-child transmission of HIV (PMTCT) and the management of HIV in children, adolescents, and adults [homepage on the Internet]"},{"key":"ref0005","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir307"},{"key":"ref0006","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyx136"},{"key":"ref0007","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofx187"},{"key":"ref0008","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000000909"},{"key":"ref0009","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv389"},{"key":"ref0010","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis553"},{"key":"ref0011","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-019022"},{"key":"ref0012","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1807653"},{"key":"ref0013","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001635"},{"key":"ref0014","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e318235c7aa"},{"key":"ref0015","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2017.10.003"},{"issue":"10","key":"ref0016","first-page":"e172222","volume":"171","author":"Zash","year":"2017","journal-title":"JAMA Paed"},{"key":"ref0017","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000000847"},{"key":"ref0018","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(16)30195-3"},{"key":"ref0019","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu393"},{"key":"ref0020","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000231"},{"key":"ref0021","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328352d135"},{"key":"ref0022","author":"Van Dyke","year":"2016","journal-title":"Front Immunol"},{"key":"ref0023","author":"Antiretroviral Pregnancy Registry Steering Committee","year":"2019","journal-title":"Antiretroviral Pregnancy Registry Steering Committee, Antiretroviral pregnancy registry international interim report for 1 January 1989 through 31 January 2018 [homepage on the Internet]"},{"key":"ref0024","author":"US Department of Health and Human Services, AIDSinfo","year":"2019","journal-title":"US Department of Health and Human Services, AIDSinfo: Recommendations for the use of antiretroviral drugs in pregnant women with HIV infection and interventions to reduce perinatal HIV transmission in the United States [cited 2019 Apr 27]"},{"key":"ref0025","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001711"},{"key":"ref0026","first-page":"181","volume":"5","author":"Prestes-Carneiro","year":"2013","journal-title":"HIV AIDS"},{"key":"ref0027","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ437"},{"key":"ref0028","author":"The 2015 National Antenatal Sentinel HIV and Herpes Simplex type-2 prevalence Survey","year":"2019","journal-title":"The 2015 National Antenatal Sentinel HIV and Herpes Simplex type-2 prevalence Survey [homepage on the Internet]"},{"key":"ref0029","first-page":"77","author":"Massyn","year":"2017","journal-title":"District Health Barometer 2016\/17 [homepage on the Internet]"},{"key":"ref0030","author":"World Health Organization\/Centers for Disease Control and Prevention\/International Clearinghouse for Birth Defects Surveillance and Research (WHO\/CDC\/ICBDSR)","year":"2014","journal-title":"Birth defects surveillance: A manual for programme managers [homepage on the Internet]"},{"key":"ref0031","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.20842"},{"key":"ref0032","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0000000000000772"},{"key":"ref0033","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000394"},{"key":"ref0034","author":"Holmes","year":"2012","journal-title":"Common malformations"},{"key":"ref0035","doi-asserted-by":"publisher","DOI":"10.1016\/S1701-2163(15)30279-6"},{"key":"ref0036","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002290"},{"key":"ref0037","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0198447"},{"key":"ref0038","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001673"}],"container-title":["Southern African Journal of HIV Medicine"],"original-title":[],"link":[{"URL":"https:\/\/sajhivmed.org.za\/index.php\/hivmed\/article\/viewFile\/971\/1641","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/sajhivmed.org.za\/index.php\/hivmed\/article\/viewFile\/971\/1640","content-type":"application\/epub+zip","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/sajhivmed.org.za\/index.php\/hivmed\/article\/viewFile\/971\/1642","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/sajhivmed.org.za\/index.php\/hivmed\/article\/viewFile\/971\/1639","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/sajhivmed.org.za\/index.php\/hivmed\/article\/viewFile\/971\/1639","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T11:28:08Z","timestamp":1569842888000},"score":1,"resource":{"primary":{"URL":"https:\/\/sajhivmed.org.za\/index.php\/hivmed\/article\/view\/971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,30]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1,23]]}},"URL":"https:\/\/doi.org\/10.4102\/sajhivmed.v20i1.971","relation":{},"ISSN":["2078-6751","1608-9693"],"issn-type":[{"value":"2078-6751","type":"electronic"},{"value":"1608-9693","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9,30]]}}}